C90 Multiple myeloma and malignant plasma cell neoplasms - analogs
Description «C90 Multiple myeloma and malignant plasma cell neoplasms» | ||||||
|
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 10% Compare C34.3 Malignant neoplasm, lower lobe, bronchus or lung
- 10% Compare C71.3 Malignant neoplasm, parietal lobe
- 10% Compare C64 Malignant neoplasm of kidney, except renal pelvis
- 10% Compare C65 Malignant neoplasm of renal pelvis
- 10% Compare D07.4 Carcinoma in situ, penis
- 10% Compare C71.2 Malignant neoplasm, temporal lobe
- 10% Compare C49.2 Malignant neoplasm, connective and soft tissue of lower limb, including hip
- 10% Compare C71.1 Malignant neoplasm, frontal lobe
- 10% Compare C71.0 Malignant neoplasm, cerebrum, except lobes and ventricles
- 10% Compare C24 Malignant neoplasm of other and unspecified parts of biliary tract
- 10% Compare C68.0 Malignant neoplasm, urethra
- 10% Compare C79.8 Secondary malignant neoplasm of other specified sites
- 10% Compare C34 Malignant neoplasm of bronchus and lung
- 10% Compare C34.2 Malignant neoplasm, middle lobe, bronchus or lung
- 10% Compare C69.3 Malignant neoplasm, choroid
- 10% Compare C34.0 Malignant neoplasm, main bronchus
- 10% Compare C49.5 Malignant neoplasm, connective and soft tissue of pelvis
- 10% Compare C23 Malignant neoplasm of gallbladder
- 10% Compare C71.5 Malignant neoplasm, cerebral ventricle
- 10% Compare C34.8 Malignant neoplasm, overlapping lesion of bronchus and lung
- 10% Compare C45-C49 Malignant neoplasms of mesothelial and soft tissues
- 10% Compare C09 Malignant neoplasm of tonsil
- 10% Compare C22.1 Malignant neoplasm, intrahepatic bile duct carcinoma
- 10% Compare C01 Malignant neoplasm of base of tongue
- 10% Compare C49.6 Malignant neoplasm, connective and soft tissue of trunk, unspecified
- 10% Compare C38.4 Malignant neoplasm, pleura
- 10% Compare C60 Malignant neoplasm of penis
- 10% Compare C73 Malignant neoplasm of thyroid gland
- 10% Compare C70 Malignant neoplasm of meninges
- 10% Compare C48 Malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C70.9 Malignant neoplasm, meninges, unspecified
- 10% Compare B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
- 10% Compare C48.8 Malignant neoplasm, overlapping lesion of retroperitoneum and peritoneum
- 10% Compare C71.4 Malignant neoplasm, occipital lobe
- 10% Compare C49.8 Malignant neoplasm, overlapping lesion of connective and soft tissue
- 10% Compare C05 Malignant neoplasm of palate
- 10% Compare D29 Benign neoplasm of male genital organs
- 10% Compare C58 Malignant neoplasm of placenta
- 10% Compare C76.2 Malignant neoplasm, abdomen
- 10% Compare C06.9 Malignant neoplasm, mouth, unspecified
- 10% Compare C06 Malignant neoplasm of other and unspecified parts of mouth
- 10% Compare C33 Malignant neoplasm of trachea
- 10% Compare C69 Malignant neoplasm of eye and adnexa
- 10% Compare B21.9 HIV disease resulting in unspecified malignant neoplasm
- 10% Compare B21.8 HIV disease resulting in other malignant neoplasms
- 10% Compare C02 Malignant neoplasm of other and unspecified parts of tongue
- 10% Compare Z51.0 Radiotherapy session
- 10% Compare C47.6 Malignant neoplasm, peripheral nerves of trunk, unspecified
- 10% Compare B21.7 HIV disease resulting in multiple malignant neoplasms
- 10% Compare C57.9 Malignant neoplasm, female genital organ, unspecified
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.